Evidence map›Paper›PMID 33239247›Full record

Observational studyMedicina clinica2021

[Alternative CPAP methods for the treatment of secondary serious respiratory failure due to pneumonia by COVID-19].

Alonso Mateos-Rodríguez, Justo Ortega-Anselmi, Francisco Javier Candel-González, Jesús Canora-Lebrato, Marcos Fragiel-Saavedra, Alba Hernández-Píriz, Navid Behzadi-Koocahni, Juan González-Del Castillo, Antonio Pérez-Alonso, María Luisa de la Cruz-Conty and 3 more

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in Medicina clinica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Alonso Mateos-RodríguezHospital de Campaña IFEMA COVID-19, Madrid, España; Servicio de Urgencias Médicas de Madrid SUMMA112, Madrid, España; Facultad de Medicina, Universidad Francisco de Vitoria, Madrid, España. Electronic address: alonso.mateos@salud.madrid.org.
Justo Ortega-AnselmiHospital de Campaña IFEMA COVID-19, Madrid, España; Hospital Universitario Clínico San Carlos, Madrid, España.
Francisco Javier Candel-GonzálezHospital de Campaña IFEMA COVID-19, Madrid, España; Hospital Universitario Clínico San Carlos, Madrid, España.
Jesús Canora-LebratoHospital de Campaña IFEMA COVID-19, Madrid, España; Hospital Universitario de Fuenlabrada, Madrid, España.
Marcos Fragiel-SaavedraHospital de Campaña IFEMA COVID-19, Madrid, España; Hospital Universitario Clínico San Carlos, Madrid, España.
Alba Hernández-PírizHospital de Campaña IFEMA COVID-19, Madrid, España; Hospital Universitario de Fuenlabrada, Madrid, España.
Navid Behzadi-KoocahniHospital de Campaña IFEMA COVID-19, Madrid, España; Servicio de Urgencias Médicas de Madrid SUMMA112, Madrid, España.
Juan González-Del CastilloHospital de Campaña IFEMA COVID-19, Madrid, España; Hospital Universitario Clínico San Carlos, Madrid, España.
Antonio Pérez-AlonsoHospital de Campaña IFEMA COVID-19, Madrid, España; Servicio de Asistencia Municipal de Urgencias y Rescates-Protección Civil, Madrid, España.
María Luisa de la Cruz-ContyFacultad de Medicina, Universidad Francisco de Vitoria, Madrid, España.
Gonzalo García-de CasasolaHospital de Campaña IFEMA COVID-19, Madrid, España; Hospital Universitario Infanta Cristina, Madrid, España.
Javier Marco-MartínezHospital de Campaña IFEMA COVID-19, Madrid, España; Hospital Universitario Clínico San Carlos, Madrid, España.
Antonio Zapatero-GaviriaHospital de Campaña IFEMA COVID-19, Madrid, España; Hospital Universitario de Fuenlabrada, Madrid, España.
Hospital Clínico San Carlos · ESHospital Universitario de Fuenlabrada · ESUniversidad Francisco de Vitoria · ESHospital Universitario Infanta Cristina · ESMadrid Health Service · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe use of devices that provide continuous positive pressure in the airway has shown improvement in various pathologies that cause respiratory failure. In the COVID-19 pandemic episode the use of these devices has become widespread, but, due to the shortage of conventional continuous positive airway pressure (CPAP) devices, alternative devices have been manufactured. The objective of this study is to describe the use of these devices, as well as their efficacy. MATERIAL AND

methodsData are collected from patients admitted for pneumonia due to COVID-19 at the IFEMA Field Hospital. Data are collected from 23 patients with respiratory failure and need for ventilatory support.

resultsStudy carried out on a total of 23 patients, dated admission to IFEMA. Alternative CPAP was used in five patients (21.7%), while ventilatory support with a reservoir mask or Ventimask Venturi effect was used in the remaining 18 patients (78.3%). A progressive increase in saturation is observed in those patients in whom alternative CPAP was used (from 94% on average to 98 and 99% on average after 30 and 60 minutes with the mask, respectively), although this change was not significant (p = 0.058 and p = 0.122, respectively). No significant change in RF was observed at the beginning and end of the measurement in patients who used alternative CPAP (p = 0.423), but among those who did not use alternative CPAP (p = 0.001). A statistically significant improvement in the variable oxygen saturation / fraction inspired by oxygen is observed in patients who used alternative CPAP (p = 0.040)

conclusionThe use of these devices has helped the ventilatory work of several patients by improving their oxygenation parameters. To better observe the evolution of patients undergoing this therapy and compare them with patients with other types of ventilatory support, further studies are necessary.

Indexed as

AdultAgedAged, 80 and overContinuous Positive Airway PressureCOVID-19FemaleHumansMaleMiddle AgedRespiratory InsufficiencyTreatment OutcomeCOVID-19CPAPInsuficiencia respiratoriaRespiratory insufficience

Identifiers

PMID33239247
PMCPMC7833909
OpenAlexW3095775010

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.